Dan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dan Zhang has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
Shan Xu
Department of Emergency Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
8 shared publicationsFu Wei
Department of Emergency, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China
4 shared publicationsJinglun Liu
Department of Emergency and Critical Care Medicine, The First Afliated Hospital of Chongqing Medical University, Chongqing 400016, PR China
4 shared publicationsLi Luo
Department of Emergency, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China; Department of emergency, the Third People's Hospital of Chengdu, the Second Affiliated Chengdu Clinical College of Chongqing Medical University, Chengdu, Sichuan, 610031, PR China
3 shared publications- Shan Xu
Department of Emergency, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
3 shared publications Xian Liu
Department of Emergency & Critical care Unit the First Affiliated Hospital of Chongqing Medical University Chongqing China
3 shared publications
Latest Publications
- Open Access
- 30 May 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 30, 200654
Clinical subtypes and prognosis of new-onset atrial fibrillation in critically ill patients
- 30 May 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 30, 200654
Open AccessClinical subtypes and prognosis of new-onset atrial fibrillation in critically ill patients
- Open Access
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101617
A cohort study on the A8G6 neutralizing antibody intranasal spray for preventing SARS-CoV-2 infection in healthcare workers
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101617
Open AccessA cohort study on the A8G6 neutralizing antibody intranasal spray for preventing SARS-CoV-2 infection in healthcare workers
- Open Access
- 8 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16
SHKBP1 is a target for sepsis: evidence from WGCNA and multiple machine learning algorithms
Background: Identifying novel biomarkers for sepsis is essential for improving patient outcomes. Cuproptosis, a recently discovered form of cell death associated with various diseases, has an unclear relationship with sepsis. This study aimed to elucidate the expression patterns of cuproptosis-related genes(CRGs) in sepsis, identifying potential biomarkers and therapeutic targets. Methods: We investigated the expression patterns of cuproptosis-related genes in sepsis and performed consensus clustering. A diagnostic model for sepsis was constructed using weighted gene co-expression network analysis (WGCNA) combined with four machine learning algorithms. Prognosis-related genes were identified via Kaplan-Meier survival analysis and validated in septic mice. Results: We identified 28 differentially expressed CRGs and characterized a specific immune landscape. Our findings showed that sepsis samples could be divided into two clusters based on CRGs expression. We established a diagnostic model based on five key genes(SHKBP1,ICAM2,CTSD,SNX3, and SLC22A4), and Kaplan-Meier survival analysis revealed that SHKBP1 was significantly correlated with both the diagnosis and prognosis of sepsis. Conclusion: Our study provides a comprehensive analysis of CRGs expression in sepsis, establishes a diagnostic model, and identifies SHKBP1 as a biomarker for both diagnosis and prognosis prediction, offering new insights for sepsis management.
- 8 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16
Open AccessSHKBP1 is a target for sepsis: evidence from WGCNA and multiple machine learning algorithms
Background: Identifying novel biomarkers for sepsis is essential for improving patient outcomes. Cuproptosis, a recently discovered form of cell death associated with various diseases, has an unclear relationship with sepsis. This study aimed to elucidate the expression patterns of cuproptosis-related genes(CRGs) in sepsis, identifying potential biomarkers and therapeutic targets. Methods: We investigated the expression patterns of cuproptosis-related genes in sepsis and performed consensus clustering. A diagnostic model for sepsis was constructed using weighted gene co-expression network analysis (WGCNA) combined with four machine learning algorithms. Prognosis-related genes were identified via Kaplan-Meier survival analysis and validated in septic mice. Results: We identified 28 differentially expressed CRGs and characterized a specific immune landscape. Our findings showed that sepsis samples could be divided into two clusters based on CRGs expression. We established a diagnostic model based on five key genes(SHKBP1,ICAM2,CTSD,SNX3, and SLC22A4), and Kaplan-Meier survival analysis revealed that SHKBP1 was significantly correlated with both the diagnosis and prognosis of sepsis. Conclusion: Our study provides a comprehensive analysis of CRGs expression in sepsis, establishes a diagnostic model, and identifies SHKBP1 as a biomarker for both diagnosis and prognosis prediction, offering new insights for sepsis management.
- Open Access
- 4 August 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-13
The relationship between clinical subtypes, prognosis, and treatment in ICU patients with acute cholangitis using unsupervised machine learning methods
Acute cholangitis (AC) presents with significant clinical heterogeneity, and existing severity classifications have limited prognostic value in critically ill patients. Subtypes of AC in critically ill patients have not been investigated. The study aimed to offer a novel approach to identify clinical subtypes and improve individualized risk assessment and treatment strategies using an unsupervised analysis. We conducted a retrospective analysis of ICU patients with AC from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. K-means clustering was applied to 24 routinely available clinical variables from the first 24 h of ICU admission to identify clinical subtypes. The primary outcome was 28-day all-cause mortality. Multivariable Cox regression was used to assess associations between subtypes, mortality, and biliary drainage strategies. Furthermore, a simplified model using the top five SHapley Additive exPlanations (SHAP) ranked variables (hemoglobin, RDW, albumin, CCI, and sodium) was developed and subsequently validated in an external cohort from MIMIC-III. Two distinct subtypes were identified: a mild-inflammatory subtype (n = 451) and an inflammatory-dysfunctional subtype (n = 348). The inflammatory-dysfunctional subtype was characterized by higher levels of RDW, ALP, bilirubin, creatinine, and coagulopathy markers, and exhibited significantly higher 28-day mortality (30.17% vs. 5.32%, p < 0.001). This subtype remained an independent predictor of mortality after multivariable adjustment (HR = 2.38,95%CI:1.42–3.9, p = 0.001). Within the inflammatory-dysfunctional subtype, ERCP was associated with lower mortality (HR = 0.56, p = 0.01), whereas PTCD was associated with higher mortality (HR = 1.63, p = 0.031), potentially reflecting underlying disease severity. The simplified model retained strong discriminative performance (AUC = 0.87) and was successfully validated in the external cohort, confirming the reproducibility and prognostic relevance of the subtypes. We identified and externally validated two clinically meaningful AC subtypes with distinct prognoses. A simplified model using five readily available variables facilitates clinical application and can support more individualized treatment approaches. These data-driven subtypes offer additional prognostic discrimination beyond the Tokyo Guidelines, serving as a valuable complement to existing severity classifications for guiding precision management of ICU patients with AC.
- 4 August 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-13
Open AccessThe relationship between clinical subtypes, prognosis, and treatment in ICU patients with acute cholangitis using unsupervised machine learning methods
Acute cholangitis (AC) presents with significant clinical heterogeneity, and existing severity classifications have limited prognostic value in critically ill patients. Subtypes of AC in critically ill patients have not been investigated. The study aimed to offer a novel approach to identify clinical subtypes and improve individualized risk assessment and treatment strategies using an unsupervised analysis. We conducted a retrospective analysis of ICU patients with AC from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. K-means clustering was applied to 24 routinely available clinical variables from the first 24 h of ICU admission to identify clinical subtypes. The primary outcome was 28-day all-cause mortality. Multivariable Cox regression was used to assess associations between subtypes, mortality, and biliary drainage strategies. Furthermore, a simplified model using the top five SHapley Additive exPlanations (SHAP) ranked variables (hemoglobin, RDW, albumin, CCI, and sodium) was developed and subsequently validated in an external cohort from MIMIC-III. Two distinct subtypes were identified: a mild-inflammatory subtype (n = 451) and an inflammatory-dysfunctional subtype (n = 348). The inflammatory-dysfunctional subtype was characterized by higher levels of RDW, ALP, bilirubin, creatinine, and coagulopathy markers, and exhibited significantly higher 28-day mortality (30.17% vs. 5.32%, p < 0.001). This subtype remained an independent predictor of mortality after multivariable adjustment (HR = 2.38,95%CI:1.42–3.9, p = 0.001). Within the inflammatory-dysfunctional subtype, ERCP was associated with lower mortality (HR = 0.56, p = 0.01), whereas PTCD was associated with higher mortality (HR = 1.63, p = 0.031), potentially reflecting underlying disease severity. The simplified model retained strong discriminative performance (AUC = 0.87) and was successfully validated in the external cohort, confirming the reproducibility and prognostic relevance of the subtypes. We identified and externally validated two clinically meaningful AC subtypes with distinct prognoses. A simplified model using five readily available variables facilitates clinical application and can support more individualized treatment approaches. These data-driven subtypes offer additional prognostic discrimination beyond the Tokyo Guidelines, serving as a valuable complement to existing severity classifications for guiding precision management of ICU patients with AC.
- 16 July 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 496, 139273
Genome-wide association and epidemiological evidence linking air pollution to aging mechanisms
- 16 July 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 496, 139273
Genome-wide association and epidemiological evidence linking air pollution to aging mechanisms
- Open Access
- 20 January 2025
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2025 (1)
Clinical Subtypes and Prognostic Outcomes of Rhabdomyolysis in ICU Patients
Background: Rhabdomyolysis (RM) is a severe clinical syndrome with substantial heterogeneity that involves the rapid dissolution of skeletal muscles. The condition has a high prevalence and poor prognosis, particularly in critically ill patients. Subtypes of RM in critically ill patients have not been investigated. Objective: The study aimed to link the clinical RM heterogeneity with distinct prognoses and associated characteristics among different subtypes using an unsupervised analysis. Methods: Patients diagnosed with RM in the intensive care unit (ICU) from the Medical Information Mart for Intensive Care‐IV (MIMIC‐IV) database and the eICU Collaborative Research Database (eICU) were retrospectively enrolled. K‐means clustering, guided by correlation coefficients and expert opinions in intensive care medicine, was applied to identify distinct RM clinical subtypes using routinely available parameters from the first 24 h after patient ICU admission. The primary endpoint was 28‐day mortality. We assessed associations between subtypes and 28‐day mortality, as well as between treatments and 28‐day mortality in the derived subtypes, using multivariate Cox proportional hazards regression. The eICU database patients served as an external validation set. The SHapley Additive exPlanations (SHAPs) were used to visualize features of each clinical subtype. Results: A total of 2269 eligible subjects were extracted from the MIMIC‐IV. Two distinct subtypes were identified (A and B) using 17 readily available clinical and biological variables. Patients assigned to Subtype A ( n = 511) had a higher 28‐day mortality. The proportion of organ support, comorbidity index, SAPS II, and SOFA scores were all significantly higher in the Subtype A group than in the Subtype B group ( n = 1836). After adjusting for relevant covariates, Subtype A patients were independently associated with increased 28‐day mortality (HR [95% CI] = 1.70 [1.36–2.11], p < 0.001). These findings were further validated using an external cohort from the eICU dataset. Notably, Subtype A patients showed a higher mortality risk associated with sodium bicarbonate use (HR [95% CI] 1.62 [1.20–2.19], p = 0.002). Conclusions: We identified two subtypes with distinct clinical features and outcomes. Subtype A is independently associated with poor outcomes and shows increased mortality risk with sodium bicarbonate use. These findings may help clinicians better distinguish prognoses and treatment responses among RM patients.
- 20 January 2025
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2025 (1)
Open AccessClinical Subtypes and Prognostic Outcomes of Rhabdomyolysis in ICU Patients
Background: Rhabdomyolysis (RM) is a severe clinical syndrome with substantial heterogeneity that involves the rapid dissolution of skeletal muscles. The condition has a high prevalence and poor prognosis, particularly in critically ill patients. Subtypes of RM in critically ill patients have not been investigated. Objective: The study aimed to link the clinical RM heterogeneity with distinct prognoses and associated characteristics among different subtypes using an unsupervised analysis. Methods: Patients diagnosed with RM in the intensive care unit (ICU) from the Medical Information Mart for Intensive Care‐IV (MIMIC‐IV) database and the eICU Collaborative Research Database (eICU) were retrospectively enrolled. K‐means clustering, guided by correlation coefficients and expert opinions in intensive care medicine, was applied to identify distinct RM clinical subtypes using routinely available parameters from the first 24 h after patient ICU admission. The primary endpoint was 28‐day mortality. We assessed associations between subtypes and 28‐day mortality, as well as between treatments and 28‐day mortality in the derived subtypes, using multivariate Cox proportional hazards regression. The eICU database patients served as an external validation set. The SHapley Additive exPlanations (SHAPs) were used to visualize features of each clinical subtype. Results: A total of 2269 eligible subjects were extracted from the MIMIC‐IV. Two distinct subtypes were identified (A and B) using 17 readily available clinical and biological variables. Patients assigned to Subtype A ( n = 511) had a higher 28‐day mortality. The proportion of organ support, comorbidity index, SAPS II, and SOFA scores were all significantly higher in the Subtype A group than in the Subtype B group ( n = 1836). After adjusting for relevant covariates, Subtype A patients were independently associated with increased 28‐day mortality (HR [95% CI] = 1.70 [1.36–2.11], p < 0.001). These findings were further validated using an external cohort from the eICU dataset. Notably, Subtype A patients showed a higher mortality risk associated with sodium bicarbonate use (HR [95% CI] 1.62 [1.20–2.19], p = 0.002). Conclusions: We identified two subtypes with distinct clinical features and outcomes. Subtype A is independently associated with poor outcomes and shows increased mortality risk with sodium bicarbonate use. These findings may help clinicians better distinguish prognoses and treatment responses among RM patients.
- 20 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112719
Andrographolide ameliorates sepsis-induced acute lung injury by promoting autophagy in alveolar macrophages via the RAGE/PI3K/AKT/mTOR pathway
- 20 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112719
Andrographolide ameliorates sepsis-induced acute lung injury by promoting autophagy in alveolar macrophages via the RAGE/PI3K/AKT/mTOR pathway
- RetractedOpen Access
- 12 November 2023
- Published by Wiley in International Wound Journal
- Vol. 21 (3)
RETRACTED: Meta‐analysis on the efficacy of Traditional Chinese Medicine in enhancing surgical site wound healing post‐colorectal surgery
This meta‐analysis aimed to evaluate the efficacy of Traditional Chinese Medicine (TCM) in enhancing surgical site wound healing following colorectal surgery. We systematically reviewed and analysed randomized controlled trials (RCTs) that investigated the outcomes of TCM interventions in postoperative wound management, adhering to the PRISMA guidelines. The primary outcome was the assessment of wound healing through the REEDA (redness, oedema, ecchymosis, discharge and approximation) scale at two different time points: the 10th day and 1‐month post‐surgery. Seven RCTs involving 1884 patients were included. The meta‐analysis revealed a statistically significant improvement in wound healing in the TCM‐treated groups compared to the control groups at both time intervals. On the 10th day post‐surgery, the TCM groups exhibited a significant reduction in REEDA scale scores (I2 = 98%; random: SMD: −2.25, 95% CI: −3.52 to −0.98, p < 0.01). A similar trend was observed 1‐month post‐surgery, with the TCM groups showing a substantial decrease in REEDA scale scores (I2 = 98%; random: SMD: ‐3.39, 95% CI: −4.77 to −2.01, p < 0.01). Despite the promising results, the majority of the included studies were of suboptimal quality, indicating a need for further high‐quality RCTs to substantiate the findings. The results suggest that TCM interventions can potentially enhance wound healing post‐colorectal surgery, paving the way for further research in this area to validate the efficacy of TCM in postoperative management.
- 12 November 2023
- Published by Wiley in International Wound Journal
- Vol. 21 (3)
RetractedOpen AccessRETRACTED: Meta‐analysis on the efficacy of Traditional Chinese Medicine in enhancing surgical site wound healing post‐colorectal surgery
This meta‐analysis aimed to evaluate the efficacy of Traditional Chinese Medicine (TCM) in enhancing surgical site wound healing following colorectal surgery. We systematically reviewed and analysed randomized controlled trials (RCTs) that investigated the outcomes of TCM interventions in postoperative wound management, adhering to the PRISMA guidelines. The primary outcome was the assessment of wound healing through the REEDA (redness, oedema, ecchymosis, discharge and approximation) scale at two different time points: the 10th day and 1‐month post‐surgery. Seven RCTs involving 1884 patients were included. The meta‐analysis revealed a statistically significant improvement in wound healing in the TCM‐treated groups compared to the control groups at both time intervals. On the 10th day post‐surgery, the TCM groups exhibited a significant reduction in REEDA scale scores (I2 = 98%; random: SMD: −2.25, 95% CI: −3.52 to −0.98, p < 0.01). A similar trend was observed 1‐month post‐surgery, with the TCM groups showing a substantial decrease in REEDA scale scores (I2 = 98%; random: SMD: ‐3.39, 95% CI: −4.77 to −2.01, p < 0.01). Despite the promising results, the majority of the included studies were of suboptimal quality, indicating a need for further high‐quality RCTs to substantiate the findings. The results suggest that TCM interventions can potentially enhance wound healing post‐colorectal surgery, paving the way for further research in this area to validate the efficacy of TCM in postoperative management.